Literature DB >> 29770304

Current role of interventional radiology in the management of visceral and bone metastases from thyroid cancer.

Roberto Luigi Cazzato1, Julien Garnon1, Guillaume Koch1, Behnam Shaygi2, Georgia Tsoumakidou1, Jean Caudrelier1, Emanuele Boatta1, Xavier Buy3, Jean Palussiere3, Afshin Gangi1.   

Abstract

The metastatic disease from thyroid cancer represents a complex clinical scenario, which mandates a case-based multi-disciplinary approach in tertiary referral centers. Direct localised treatments such as minimally invasive interventional radiology procedures can play a vital role in providing a timely palliative or curative treatment in accordance with the patients' clinical status. In this narrative review, we present the current status of interventional radiology treatments for the management of thyroid cancer distant metastases.

Entities:  

Keywords:  Thyroid cancer; bone metastases; cementoplasty; cryosurgery; embolization; osteosynthesis; thermal ablation

Year:  2018        PMID： 29770304      PMCID： PMC5938279          DOI： 10.21037/gs.2017.12.08

Source DB:  PubMed          Journal:  Gland Surg        ISSN： 2227-684X


  27 in total

Review 1.  Principles of and advances in percutaneous ablation.

Authors:  Muneeb Ahmed; Christopher L Brace; Fred T Lee; S Nahum Goldberg
Journal:  Radiology       Date:  2011-02       Impact factor: 11.105

Review 2.  Thyroid cancer.

Authors:  Maria E Cabanillas; David G McFadden; Cosimo Durante
Journal:  Lancet       Date:  2016-05-27       Impact factor: 79.321

3.  Percutaneous osteoplasty combined with radioiodine therapy as a treatment for bone metastasis developing after differentiated thyroid carcinoma.

Authors:  Hong-Jun Song; Chun-Gen Wu; Yan-Li Xue; Yan-Hong Xu; Zhong-Ling Qiu; Quan-Yong Luo
Journal:  Clin Nucl Med       Date:  2012-06       Impact factor: 7.794

Review 4.  The role of hepatic trans-arterial chemoembolization in metastatic medullary thyroid carcinoma: a specialist center experience and review of the literature.

Authors:  S Grozinsky-Glasberg; A I Bloom; N Lev-Cohain; A Klimov; H Besiso; D J Gross
Journal:  Eur J Endocrinol       Date:  2017-01-18       Impact factor: 6.664

5.  Over ten years of single-institution experience in percutaneous image-guided treatment of bone metastases from differentiated thyroid cancer.

Authors:  R L Cazzato; F Bonichon; X Buy; Y Godbert; B H de Figuereido; V Pointillart; J Palussière
Journal:  Eur J Surg Oncol       Date:  2015-06-21       Impact factor: 4.424

6.  Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991.

Authors:  F D Gilliland; W C Hunt; D M Morris; C R Key
Journal:  Cancer       Date:  1997-02-01       Impact factor: 6.860

Review 7.  Differentiated thyroid cancer: "complete" rational approach.

Authors:  E Kebebew; O H Clark
Journal:  World J Surg       Date:  2000-08       Impact factor: 3.352

8.  Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma.

Authors:  C F A Eustatia-Rutten; J A Romijn; M J Guijt; G J Vielvoye; R van den Berg; E P M Corssmit; A M Pereira; J W A Smit
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

9.  Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center.

Authors:  Waleed Shady; Elena N Petre; Mithat Gonen; Joseph P Erinjeri; Karen T Brown; Anne M Covey; William Alago; Jeremy C Durack; Majid Maybody; Lynn A Brody; Robert H Siegelbaum; Michael I D'Angelica; William R Jarnagin; Stephen B Solomon; Nancy E Kemeny; Constantinos T Sofocleous
Journal:  Radiology       Date:  2015-08-12       Impact factor: 11.105

10.  Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases.

Authors:  T de Baère; A Aupérin; F Deschamps; P Chevallier; Y Gaubert; V Boige; M Fonck; B Escudier; J Palussiére
Journal:  Ann Oncol       Date:  2015-02-16       Impact factor: 32.976
View more
  5 in total

Review 1.  2019 European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer.

Authors:  Laura Fugazzola; Rossella Elisei; Dagmar Fuhrer; Barbara Jarzab; Sophie Leboulleux; Kate Newbold; Jan Smit
Journal:  Eur Thyroid J       Date:  2019-08-28

Review 2.  Update on Preoperative Embolization of Bone Metastases.

Authors:  Jingqin Ma; Thomas Tullius; Thuong G Van Ha
Journal:  Semin Intervent Radiol       Date:  2019-08-19       Impact factor: 1.513

Review 3.  Percutaneous consolidation of bone metastases: strategies and techniques.

Authors:  Roberto Luigi Cazzato; Julien Garnon; Benham Shaygi; Emanuele Boatta; Guillaume Koch; Jean Palussiere; Xavier Buy; Afshin Gangi
Journal:  Insights Imaging       Date:  2019-02-06

4.  Image-Guided Thermal Ablation as an Alternative to Surgery for Papillary Thyroid Microcarcinoma: Preliminary Results of an Italian Experience.

Authors:  Giovanni Mauri; Franco Orsi; Serena Carriero; Paolo Della Vigna; Elvio De Fiori; Dario Monzani; Gabriella Pravettoni; Enrica Grosso; Marco F Manzoni; Mohssen Ansarin; Gioacchino Giugliano
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-08       Impact factor: 5.555

Review 5.  Bone metastases from differentiated thyroid carcinoma: current knowledge and open issues.

Authors:  A Nervo; A Ragni; F Retta; M Gallo; A Piovesan; V Liberini; M Gatti; U Ricardi; D Deandreis; E Arvat
Journal:  J Endocrinol Invest       Date:  2020-08-03       Impact factor: 4.256
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.